Thus, Use of ERCC1, MDR1, BRCA1, and Snail in combination with DYRK2 may further improve the accuracy of predicting survival in bladder cancer patients treated with neoadjuvant chemotherapy. The gene discussed is ERCC1; the disease is urinary bladder cancer.